Premium
The clinical conundrum of managing relapsed small cell lung cancer
Author(s) -
Nazha Bassel,
Owonikoko Taofeek K.
Publication year - 2019
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31849
Subject(s) - medicine , lung cancer , refractory (planetary science) , cancer , intensive care medicine , oncology , physics , astrobiology
The management of patients with relapsed/refractory small cell lung cancer is a true clinical conundrum. Using a common but challenging clinical scenario, this article discusses treatment considerations and promising emergent data on immune checkpoint inhibitor therapy and targeted therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom